Curated News
By: NewsRamp Editorial Staff
March 09, 2026
SS Innovations Secures $18.6M to Fuel Global Robotic Surgery Expansion
TLDR
- SS Innovations secured $18.6 million in private funding, providing capital to expand affordable surgical robotics into US and EU markets ahead of competitors.
- SS Innovations raised $18.6 million through a private placement of 5.8 million shares at $3-4 per share, with proceeds allocated for global expansion and working capital.
- This funding advances SS Innovations' mission to democratize access to affordable robotic surgery globally, potentially improving surgical outcomes for underserved populations worldwide.
- SS Innovations' SSi Mantra surgical robot has been clinically validated in over 100 procedures in India while featuring modular arms and 3D 4K visualization technology.
Impact - Why it Matters
This development is significant because it directly addresses a major barrier in healthcare: the high cost of surgical robotics. Currently, robotic-assisted surgery is often limited to well-funded hospitals in wealthy nations due to the exorbitant price of systems like the da Vinci. SS Innovations' mission to create affordable technology could democratize access to minimally invasive, precision surgery, potentially improving patient outcomes and reducing recovery times in underserved regions globally. The insider-led funding demonstrates strong belief in this mission and provides the capital necessary to navigate rigorous regulatory pathways in the U.S. and EU. Success in these markets would introduce competition, potentially driving down costs industry-wide and accelerating the adoption of robotic surgery, benefiting healthcare systems and patients worldwide by making advanced surgical care more accessible and affordable.
Summary
SS Innovations International, Inc. (Nasdaq: SSII), a developer of innovative surgical robotic technologies, has successfully completed a significant $18.6 million private placement financing round. The funding, announced via PRISM MediaWire, a trusted press release distribution service, was led by key company insiders including Chairman and CEO Dr. Sudhir Srivastava, Vice-Chairman Dr. Frederic H. Moll, and director Tim Adams, who collectively invested approximately $5.2 million. This strong insider participation underscores their confidence in the company's mission to democratize access to affordable robotic surgery globally. The remaining $13.4 million came from existing and new investors, with Manipal Global Health Services, a major existing shareholder, taking a leading role among them.
The core purpose of this capital infusion is to fuel SS Innovations' ambitious growth initiatives. According to Dr. Srivastava, the net proceeds will be allocated toward working capital and advancing the company's global expansion, particularly in India and other existing markets. Crucially, the funds will support preparations for the highly anticipated entry into the United States and European Union markets. The company anticipates receiving U.S. Food and Drug Administration (FDA) 510(k) clearance for its flagship SSi Mantra surgical robotic system by mid-2026 and is concurrently pursuing European Union CE marking certification, also targeted for 2026. The SSi Mantra is a modular, multi-arm system clinically validated in over 100 different surgical procedures in India.
This financing represents a pivotal step for SS Innovations as it seeks to challenge the established players in the surgical robotics arena with its cost-effective and user-friendly technology. The company's strategy hinges on making advanced robotic-assisted surgery accessible to a broader global population, a vision reiterated by Dr. Srivastava in his comments. The transaction details include a commission payment and warrant issuance related to a specific investor's portion. As with all such private placements, the securities offered have not been registered under U.S. securities laws. For more information, investors and the public can visit the company's website at ssinnovations.com or follow its updates on LinkedIn.
Source Statement
This curated news summary relied on content disributed by PRISM Mediawire. Read the original source here, SS Innovations Secures $18.6M to Fuel Global Robotic Surgery Expansion
